SEC 13F Intelligence

TEVA PHARMACEUTICAL FIN LLC

CUSIP 88163VAE9

Teva Pharmaceutical Fin LLC has 7 institutional holders in Filings Flow’s 13F database, together reporting 27.84M shares worth $27M as of Q4 2021. The largest reported holders are Income Research & Management, Hightower Advisors, LLC, and Creative Planning.

Institutional Holders
7
Q4 2021
Reported Value
$27M
Ticker
unmapped
private placement or foreign
Quarters Tracked
6

Ownership Trend

Institutional holders
Q4 ’18: 39Q4 ’18Q1 ’19: 40Q1 ’19Q2 ’19: 46Q2 ’19Q3 ’19: 45Q3 ’19Q2 ’21: 6Q2 ’21Q4 ’21: 7Q4 ’21filingsflow.com
Total reported value
Q4 ’18: $368MQ4 ’18Q1 ’19: $10.0BQ1 ’19Q2 ’19: $3.0BQ2 ’19Q3 ’19: $603MQ3 ’19Q2 ’21: $12MQ2 ’21Q4 ’21: $27MQ4 ’21filingsflow.com

Holders

Mixed quarters
Manager% of PortfolioValueSharesQuarter
INCOME RESEARCH & MANAGEMENT$169M AUM4.50%$10M12.03MQ3 2022OLDER
American Portfolios Advisors$1.2B AUM0.00%$1,8512.0KQ1 2023
HighTower Advisors, LLC$94.2B AUM0.00%$30,00038.0KQ3 2022OLDER
COMMONWEALTH EQUITY SERVICES, LLC$71.6B AUM0.00%$8,00011.0KQ3 2022OLDER
Creative Planning$147.4B AUM0.00%$10,00010.0KQ3 2022OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.